Abbott to buy VC-backed Evalve for $410m

The heart valve implant maker is the second venture-backed company to be purchased by Abbott this month.

5 January 2013•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.